Clinical Trial Update: A Non-inferiority Study With Two Treatment Arms Eszopiclone 3 mg Versus Zopiclone 7.5 mg - for the Treatment of Insomnia [Phase 3]

View source ↗

Summary

A Phase 3 non-inferiority trial comparing eszopiclone 3 mg with zopiclone 7.5 mg for the treatment of insomnia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Eszopiclone (eszopiclone)
• Zopiclone (zopiclone)

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: INSOMNIA | Phase 3 | Status: COMPLETED